Change in Average Pain Scores From Baseline to Week 15/End of Treatment (EOT) Baseline to Week 15/EOT [clinicaltrials_resource:17d88bca7e9e1c5c7a630785e510c065]
Average of last 7 available scores prior to the visit, based on 11-point Likert-type numerical rating scale for pain (0=no pain, to 10=worst possible pain). This is based on a modified baseline observation carried forward (BOCF).
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change in Average Pain Scores From Baseline to Week 15/End of Treatment (EOT) Baseline to Week 15/EOT [clinicaltrials_resource:17d88bca7e9e1c5c7a630785e510c065]
Average of last 7 available scores prior to the visit, based on 11-point Likert-type numerical rating scale for pain (0=no pain, to 10=worst possible pain). This is based on a modified baseline observation carried forward (BOCF).
Bio2RDF identifier
17d88bca7e9e1c5c7a630785e510c065
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:17d88bca7e9e1c5c7a630785e510c065
measure [clinicaltrials_vocabulary:measure]
Change in Average Pain Scores From Baseline to Week 15/End of Treatment (EOT)
time frame [clinicaltrials_vocabulary:time-frame]
Baseline to Week 15/EOT
description
Average of last 7 available sc ...... vation carried forward (BOCF).
identifier
clinicaltrials_resource:17d88bca7e9e1c5c7a630785e510c065
title
Change in Average Pain Scores ...... (EOT) Baseline to Week 15/EOT
@en
type
label
Change in Average Pain Scores ...... 88bca7e9e1c5c7a630785e510c065]
@en